To treat or not to treat? That is the question

Optometry and Vision Science

Volumn 79, Issue 12, 2002, Pages 741-742

  Bullimore, Mark A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETAXOLOL;

ADULT; AGED; ARGON LASER; CONTROLLED STUDY; DECISION MAKING; EDITORIAL; FOLLOW UP; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; TIME; TRABECULOPLASTY;

BETAXOLOL; DISEASE PROGRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; TIME FACTORS; TRABECULECTOMY;

EID: 0036913644     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-200212000-00001     Document Type: Editorial

References (6)

1. Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial. Arch Ophthalmol 2002;120:1268-79.
2. Rossetti L, Marchetti I, Orzalesi N, Scorpiglione N, Torri V, Liberati A. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol 1993;111:96-103.
3. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, 2nd, Wilson MR, Gordon MO. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13; discussion 829-30.
4. Bullimore MA. My patient, my subject, my patient. Optom Vis Sci 2002;79:337.
5. TheAGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol 2001;132:311-20.
6. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology 1998;105:1146-64.